Gulf War and health 1st Edition Committee On Gulf War And Health: Infectious Diseases download pdf
Gulf War and health 1st Edition Committee On Gulf War And Health: Infectious Diseases download pdf
Gulf War and health 1st Edition Committee On Gulf War And Health: Infectious Diseases download pdf
com
https://ebookfinal.com/download/gulf-war-and-health-1st-
edition-committee-on-gulf-war-and-health-infectious-
diseases/
OR CLICK BUTTON
DOWNLOAD EBOOK
Gulf War and health 1st Edition Committee On Gulf War And
Health: A Review Of The Medical Literature Relative To The
Gulf War Veterans' Health
https://ebookfinal.com/download/gulf-war-and-health-1st-edition-
committee-on-gulf-war-and-health-a-review-of-the-medical-literature-
relative-to-the-gulf-war-veterans-health/
ebookfinal.com
https://ebookfinal.com/download/gulf-war-and-health-volume-8-update-
of-health-effects-of-serving-in-the-gulf-war-1st-edition-institute-of-
medicine/
ebookfinal.com
https://ebookfinal.com/download/the-gulf-war-1991-alastair-finlan/
ebookfinal.com
US Mechanized Infantryman in the First Gulf War Osprey
Warrior Gordon Rottman
https://ebookfinal.com/download/us-mechanized-infantryman-in-the-
first-gulf-war-osprey-warrior-gordon-rottman/
ebookfinal.com
https://ebookfinal.com/download/war-in-the-persian-gulf-reference-
library-primary-sources-1st-edition-laurie-collier-hillstorm/
ebookfinal.com
https://ebookfinal.com/download/war-in-the-persian-gulf-reference-
library-2-biographies-1st-edition-laurie-collier-hillstorm/
ebookfinal.com
https://ebookfinal.com/download/health-insurance-is-a-family-matter-
insuring-health-1st-edition-committee-on-the-consequences-of-
uninsurance/
ebookfinal.com
Abigail E. Mitchell, Laura B. Sivitz, Robert E. Black, Editors
NOTICE: The project that is the subject of this report was approved by the Governing Board of the National
Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National
Academy of Engineering, and the Institute of Medicine. The members of the committee responsible for the report
were chosen for their special competences and with regard for appropriate balance.
This study was supported by Contract V101(93)P-2155 between the National Academy of Sciences and the
Department of Veterans Affairs. Any opinions, findings, conclusions, or recommendations expressed in this
publication are those of the author(s) and do not necessarily reflect the view of the organizations or agencies that
provided support for this project.
Additional copies of this report are available from the National Academies Press, 500 Fifth Street, NW, Lockbox
285, Washington, DC 20055; (800) 624-6242 or (202) 334-3313 (in the Washington metropolitan area); Internet,
http://www.nap.edu.
For more information about the Institute of Medicine, visit the IOM home page at www.iom.edu.
The serpent has been a symbol of long life, healing, and knowledge among almost all cultures and religions since the
beginning of recorded history. The serpent adopted as a logotype by the Institute of Medicine is a relief carving from
ancient Greece, now held by the Staatliche Museen in Berlin.
The National Academy of Sciences is a private, nonprofit, self-perpetuating society of distinguished scholars
engaged in scientific and engineering research, dedicated to the furtherance of science and technology and to their
use for the general welfare. Upon the authority of the charter granted to it by the Congress in 1863, the Academy has
a mandate that requires it to advise the federal government on scientific and technical matters. Dr. Ralph J. Cicerone
is president of the National Academy of Sciences.
The National Academy of Engineering was established in 1964, under the charter of the National Academy of
Sciences, as a parallel organization of outstanding engineers. It is autonomous in its administration and in the
selection of its members, sharing with the National Academy of Sciences the responsibility for advising the federal
government. The National Academy of Engineering also sponsors engineering programs aimed at meeting national
needs, encourages education and research, and recognizes the superior achievements of engineers. Dr. Wm. A. Wulf
is president of the National Academy of Engineering.
The Institute of Medicine was established in 1970 by the National Academy of Sciences to secure the services of
eminent members of appropriate professions in the examination of policy matters pertaining to the health of the
public. The Institute acts under the responsibility given to the National Academy of Sciences by its congressional
charter to be an adviser to the federal government and, upon its own initiative, to identify issues of medical care,
research, and education. Dr. Harvey V. Fineberg is president of the Institute of Medicine.
The National Research Council was organized by the National Academy of Sciences in 1916 to associate the broad
community of science and technology with the Academy’s purposes of furthering knowledge and advising the
federal government. Functioning in accordance with general policies determined by the Academy, the Council has
become the principal operating agency of both the National Academy of Sciences and the National Academy of
Engineering in providing services to the government, the public, and the scientific and engineering communities.
The Council is administered jointly by both Academies and the Institute of Medicine. Dr. Ralph J. Cicerone and Dr.
Wm. A. Wulf are chair and vice chair, respectively, of the National Research Council.
www.national-academies.org
.
COMMITTEE ON GULF WAR AND HEALTH: INFECTIOUS DISEASES
ROBERT E. BLACK, MD, MPH, Edgar Berman Professor and Chair, Department of
International Health, Johns Hopkins University, Bloomberg School of Public Health,
Baltimore, MD
MARTIN J. BLASER, MD, Frederick H. King Professor of Internal Medicine, Chair of the
Department of Medicine, and Professor of Microbiology, New York University School of
Medicine, New York
RICHARD D. CLOVER, MD, Dean and Professor, School of Public Health and Information
Sciences, University of Louisville, KY
MYRON S. COHEN, MD, J. Herbert Bate Distinguished Professor of Medicine and
Microbiology, Immunology and Public Health, University of North Carolina School of
Medicine, Chapel Hill
JERROLD J. ELLNER, MD, Professor and Chair of the New Jersey Medical School at the
University of Medicine and Dentistry of New Jersey, Newark
JEANNE MARRAZZO, MD, MPH, Associate Professor, Department of Medicine, University
of Washington School of Medicine, Seattle
MEGAN MURRAY, MD, ScD, MPH, Assistant Professor of Epidemiology, Harvard
University, School of Public Health, Boston, MA
EDWARD C. OLDFIELD III, MD, Director, Division of Infectious Diseases, Eastern Virginia
Medical School, Norfolk
RANDALL R. REVES, MD, MSc, Professor, Division of Infectious Diseases, University of
Colorado Health Sciences Center, Denver
EDWARD T. RYAN, MD, Director, Tropical and Geographic Medicine Center, Massachusetts
General Hospital, and Associate Professor of Medicine, Harvard Medical School, Boston,
MA
STEN H. VERMUND, MD, PhD, Amos Christie Chair and Director, Vanderbilt University
Institute for Global Health, and Professor of Pediatrics, Medicine, Preventive Medicine,
and Obstetrics and Gynecology, Vanderbilt University School of Medicine, Nashville,
TN
DAWN M. WESSON, PhD, Associate Professor, Tulane School of Public Health and Tropical
Medicine, New Orleans, LA
v
STAFF
vi
REVIEWERS
This report has been reviewed in draft form by persons chosen for their diverse
perspectives and technical expertise in accordance with procedures approved by the National
Research Council’s Report Review Committee. The purpose of this independent review is to
provide candid and critical comments that will assist the institution in making its published
report as sound as possible and to ensure that the report meets institutional standards of
objectivity, evidence, and responsiveness to the study charge. The review comments and draft
manuscript remain confidential to protect the integrity of the deliberative process. We wish to
thank the following for their review of this report:
Although the reviewers listed above have provided many constructive comments and
suggestions, they were not asked to endorse the conclusions or recommendations nor did they
see the final draft of the report before its release. The review of this report was overseen by
George Rutherford, Institute of Global Health, University of California, San Francisco, and
Elaine L. Larson, School of Nursing, Columbia University. Appointed by the National Research
Council, they were responsible for making certain that an independent examination of this report
was carried out in accordance with institutional procedures and that all review comments were
carefully considered. Responsibility for the final content of this report rests entirely with the
authoring committee and the institution.
vii
PREFACE
Infectious diseases have been a problem for military personnel throughout history. The
consequences in previous conflicts have ranged from frequent illnesses disrupting daily activities
and readiness to widespread deaths. Preventive measures, early diagnosis, and treatment greatly
limit the exposures and acute illnesses of troops today in comparison with those in armies of the
past, but infections and consequent acute illnesses still occur. In addition, long-term adverse
health outcomes of some pathogens are increasingly recognized.
The deployment of about 700,000 US troops to the Persian Gulf region in the Gulf War
of 1991 potentially exposed them to pathogens that they had not encountered at home. After
returning from that short campaign, some veterans reported symptoms and expressed the concern
that they may have been exposed to biologic, chemical, or physical agents during their service in
the Persian Gulf. In response to those concerns, the US Department of Veterans Affairs (VA)
commissioned the Institute of Medicine (IOM) to review the scientific evidence on possible
long-term adverse health outcomes of exposure to specific biologic, chemical, and physical
agents and to draw conclusions on the strength of that evidence with regard to delayed and
chronic illnesses of the veterans.
The authorizing legislation for the work of IOM included several infectious diseases
endemic in the Persian Gulf region. In the charge to our committee, VA asked that we not limit
consideration to those diseases but rather include all infectious exposures that had been
documented in troops and consider their possible long-term adverse health outcomes. It further
requested that the time and geographic dimensions of the committee’s work be widened to
include military personnel deployed as part of Operation Enduring Freedom (OEF) in
Afghanistan and Operation Iraqi Freedom (OIF) in the Persian Gulf region. OEF began in 2001,
and OIF in 2003; they continued as this report went to press. The number of military personnel
involved in the more recent conflicts now exceeds that in the 1991 Gulf War. Furthermore, they
have remained for much longer periods on the average than in the Gulf War, and many have
been deployed for more than one tour in this region. Thus, the potential for exposure to endemic
pathogens is greater in these troops than in those deployed to the Gulf War. Because the possible
exposures are relatively recent, there has been only a short time to observe long-term adverse
health outcomes. The committee needed to rely on observations from the Gulf War, information
on infectious diseases in OEF and OIF, and evidence in the scientific literature to allow
conclusions to be drawn on possible long-term adverse health outcomes. With further time to
observe the possible consequences of infectious exposures, the knowledge base will increase.
Given the continuing presence of troops in the areas and the variable nature of infectious
diseases, the exposures may change.
Valuable contributions were made to this study by a number of people who shared their
expertise on infectious diseases. On behalf of the committee, I thank several of them—K. Craig
Hyams, MD, MPH, chief consultant, Occupational and Environmental Health Strategic
Healthcare Group, VA; Michael Kilpatrick, MD, deputy director, Deployment Health Support,
Department of Defense (DOD); and Alan Magill, MD, science director, Walter Reed Army
Institute of Research, for presenting information on infectious diseases that have been diagnosed
in military personnel during the Gulf War, OIF, and OEF and Richard Reithinger, PhD,
ix
x PREFACE
infectious diseases consultant, for presenting information on infectious diseases that are endemic
in southwest and south-central Asia to the committee at its May 26, 2005 meeting. I also thank
William Winkenwerder, Jr., MD, MBA, assistant secretary for defense for health affairs, and his
staff at DOD’s Deployment Health Support for expeditiously providing information to the
committee on DOD health-related policies. Finally, the committee is grateful for the insight
provided by representatives of veteran service organizations, veterans, and others who spoke
with the committee or sent in written testimony.
I am grateful for the great expertise the committee members brought to bear on this
subject. Furthermore, the report would not have been successfully completed without the diligent
and expert contributions of the IOM staff, led by Abigail Mitchell and including Laura Sivitz,
Deepali Patel, Michael Schneider, Peter James, Damika Webb, David Tollerud, and Renee
Wlodarczyk.
Summary ....................................................................................................................................1
Methodology .........................................................................................................................1
Identifying the Pathogens to Study.....................................................................................2
Development of Conclusions..............................................................................................3
Summary of Conclusions ......................................................................................................4
Sufficient Evidence of a Causal Relationship ....................................................................4
Sufficient Evidence of an Association................................................................................5
Limited or Suggestive Evidence of an Association............................................................6
Inadequate or Insufficient Evidence to Determine Whether an Association Exists...........6
Limited or Suggestive Evidence of No Association...........................................................7
Department of Defense Policies on Tuberculin Skin Testing and Predeployment and
Postdeployment Serum Collection ...................................................................................7
1 Introduction...........................................................................................................................9
Identifying the Infectious Diseases to Study.......................................................................13
The Committee’s Approach to Its Charge ..........................................................................15
Organization of the Report..................................................................................................16
References ...........................................................................................................................16
2 Methodology .......................................................................................................................19
Identifying the Infectious Diseases to Study.......................................................................19
Geographic Boundaries ....................................................................................................19
Infectious Diseases Endemic to Southwest and South-Central Asia
That Have Long-Term Adverse Health Outcomes .....................................................20
Direct Attribution to Military Service in Southwest and South-Central Asia ..................24
Timing of Appearance of Long-Term Adverse Health Outcomes ...................................27
The Infectious Diseases to Be Studied for Strength of Association
with Long-Term Adverse Health Outcomes...............................................................27
Comments on Diseases and Agents of Special Interest
to Gulf War, OEF, and OIF Veterans ..........................................................................28
Review and Evaluation of the Literature ............................................................................29
Selection of the Literature ................................................................................................29
Amassing the Literature....................................................................................................29
Reviewing the Literature ..................................................................................................29
Categories of Strength of Association.................................................................................30
Origin and Evolution of the Categories ............................................................................30
Sufficient Evidence of a Causal Relationship ..................................................................30
Sufficient Evidence of an Association..............................................................................31
Limited or Suggestive Evidence of an Association..........................................................31
Inadequate or Insufficient Evidence to Determine Whether an Association Exists.........31
xi
xii CONTENTS
4 Infectious Diseases Diagnosed in US Troops Who Served in the Persian Gulf War,
Operation Enduring Freedom, or Operation Iraqi Freedom................................................61
Diarrheal Disease ................................................................................................................62
Enteric Infections in the Gulf War....................................................................................62
Gastroenteritis in Operation Enduring Freedom and Operation Iraqi Freedom ...............69
Respiratory Disease.............................................................................................................74
Mild Acute Respiratory Disease in the Gulf War.............................................................74
Severe Acute Respiratory Disease in the Gulf War..........................................................76
Respiratory Disease in Operation Enduring Freedom and Operation Iraqi Freedom ......76
Insect-Borne Diseases .........................................................................................................78
Leishmaniasis ...................................................................................................................78
Malaria..............................................................................................................................82
West Nile Fever ................................................................................................................84
Brucellosis...........................................................................................................................84
Chicken Pox (Varicella)......................................................................................................85
Meningococcal Disease.......................................................................................................85
Nosocomial Infections ........................................................................................................85
Gulf War ...........................................................................................................................85
Operation Enduring Freedom and Operation Iraqi Freedom............................................86
Q Fever................................................................................................................................88
Q Fever Contracted During the Gulf War ........................................................................89
Q Fever Contracted During Operation Enduring Freedom
and Operation Iraqi Freedom .......................................................................................89
Viral Hepatitis .....................................................................................................................90
Tuberculosis ........................................................................................................................90
Department of Defense Medical Databases ........................................................................91
Department of Defense Policy Regarding Predeployment
and Postdeployment Serum Collection ..........................................................................93
References ...........................................................................................................................94
Brucellosis.........................................................................................................................112
Transmission and Endemicity of Brucellosis .................................................................113
Acute Brucellosis............................................................................................................114
Treatments for Brucellosis and Related Long-Term Toxicity........................................115
Coinfection .....................................................................................................................115
Long-Term Adverse Health Outcomes of Brucellosis ...................................................115
Leishmaniasis....................................................................................................................118
Transmission of Leishmaniasis.......................................................................................119
Endemicity in Southwest and South-Central Asia..........................................................120
Acute Leishmaniasis.......................................................................................................120
Diagnosis of Leishmaniasis ............................................................................................121
Treatments for Leishmaniasis and Related Long-Term Toxicity...................................121
Coinfection by Leishmania Parasite and Human Immunodeficiency Virus ..................122
Long-Term Adverse Health Outcomes of Leishmaniasis ..............................................122
Malaria ..............................................................................................................................123
Transmission of Malaria .................................................................................................124
Endemicity in Southwest and South-Central Asia..........................................................124
Acute Malaria .................................................................................................................125
Treatments for Malaria and Related Long-Term Toxicity .............................................125
Coinfection with Plasmodium Spp. and Human Immunodeficiency Virus ...................126
Long-Term Adverse Health Outcomes of Infection with Plasmodium Spp...................126
Q Fever (Infection by Coxiella burnetii) ..........................................................................129
Transmission of Coxiella burnetii ..................................................................................129
Endemicity in Southwest and South-Central Asia..........................................................130
Acute Q Fever.................................................................................................................130
Diagnosing Q Fever........................................................................................................131
Coinfection with Coxiella burnetii and Human Immunodeficiency Virus ....................131
Long-Term Adverse Health Outcomes of Q Fever ........................................................132
Tuberculosis ......................................................................................................................135
Transmission of Tuberculosis.........................................................................................135
Endemicity in Southwest and South-Central Asia..........................................................137
Risk of Progression from Latent Tuberculosis Infection to Active Tuberculosis ..........137
Treatment for Latent Tuberculosis Infection to Prevent Active Tuberculosis ...............140
Active Tuberculosis ........................................................................................................140
Late Manifestations of Active Tuberculosis...................................................................142
Potential Relationships Between Tuberculosis and Military Service.............................144
West Nile Virus Infection .................................................................................................149
Transmission of West Nile Virus Infection ....................................................................150
Endemicity in Southwest and South-Central Asia..........................................................150
Acute West Nile Fever....................................................................................................151
Diagnosis of West Nile Fever.........................................................................................151
Treatment of West Nile Virus Infection .........................................................................152
Long-Term Adverse Health Outcomes of Infection with West Nile Virus....................152
Recommendation ............................................................................................................155
References .........................................................................................................................155
xiv CONTENTS
6 Diseases and Agents of Special Concern to Veterans of the Gulf War, Operation Iraqi
Freedom, and Operation Enduring Freedom.....................................................................181
Al Eskan Disease ..............................................................................................................181
Description of Acute Illness ...........................................................................................182
Long-Term Adverse Health Outcomes...........................................................................182
Pathogenesis ...................................................................................................................182
Treatment........................................................................................................................183
Summary.........................................................................................................................183
Idiopathic Acute Eosinophilic Pneumonia........................................................................183
Description of Acute Illness ...........................................................................................183
Long-Term Adverse Health Outcomes...........................................................................183
Pathogenesis ...................................................................................................................184
Treatment........................................................................................................................184
Summary.........................................................................................................................184
Wound and Nosocomial Infections (Including Infections with Acinetobacter Spp.) ......184
Concerns Regarding Acinetobacter baumannii ..............................................................185
Other Wound Infections .................................................................................................186
Other Nosocomial Infections..........................................................................................187
Regional Experiences in Non-Americans.......................................................................188
Summary.........................................................................................................................190
Mycoplasmas ....................................................................................................................190
Mycoplasmas and “Gulf War Illness” ............................................................................191
Summary.........................................................................................................................193
Biologic-Warfare Agents ..................................................................................................193
Summary ...........................................................................................................................194
References .........................................................................................................................194
Appendix Biographical Sketches for Members of the Committee .......................................201
Index ......................................................................................................................................205
SUMMARY
Thousands of US veterans of the Persian Gulf War have reported an array of unexplained
illnesses since the war ended in 1991. Many veterans have believed that the illnesses were
associated with their military service in southwest Asia during the war. In response, the US
Congress legislated in 1998 that the Department of Veterans Affairs (VA) use a specific
procedure to determine the illnesses that warrant presumption of a connection to Gulf War
service (Public Law [PL] 105-277, Persian Gulf War Veterans Act). Moreover, VA must
financially compensate Gulf War veterans in whom the determined illnesses are diagnosed (PL
105-368, Veterans Programs Enhancement Act). To reach those determinations, the law states,
VA must obtain independent evaluations of the scientific evidence of associations between
illnesses and exposures to various chemical, physical, and biologic substances connected to
military service in southwest Asia during the war. The law instructs VA to obtain the scientific
evaluations from the National Academy of Sciences (NAS). NAS assigned the task of evaluating
the associations to the Institute of Medicine (IOM).
This report is the fifth volume produced by IOM for VA in response to the congressional
mandate.1 A committee of nationally recognized experts in infectious diseases was appointed and
charged with evaluating the scientific and medical literature on long-term adverse human health
outcomes associated with selected infectious diseases pertinent to Gulf War veterans. The
conclusions herein characterize the long-term adverse health outcomes associated with infection
by the following pathogens: Brucella species (spp.), the cause of brucellosis; Campylobacter
spp., nontyphoidal Salmonella spp. and Shigella spp., which cause diarrheal disease; Coxiella
burnetii, the cause of Q fever; Leishmania spp., the cause of leishmaniasis; Mycobacterium
tuberculosis, which causes tuberculosis; Plasmodium spp., the cause of malaria; and West Nile
virus, the cause of West Nile fever. The committee identified those pathogens through the
process outlined below. The committee then developed conclusions by studying the relevant
published evidence, deliberating to reach consensus, and responding to a formal process of peer
review.2
METHODOLOGY
IOM appointed the Committee on Gulf War and Health: Infectious Diseases in January
2005. The committee considered infections that US troops might have contracted in southwest
Asia during the Persian Gulf War. At VA’s request, the committee also examined infections that
might have afflicted US military personnel deployed to south-central and southwest Asia for
Operation Enduring Freedom (OEF)3 and Operation Iraqi Freedom (OIF).4 Thus, the
committee’s deliberations covered infectious diseases known to occur in Saudi Arabia, Kuwait,
Iraq, Afghanistan, and most countries along their borders (Yemen, Oman, United Arab Emirates,
1
Earlier IOM reports in this series present conclusions about long-term adverse health outcomes associated with
exposure to depleted uranium, pyridostigmine bromide, sarin, vaccines, insecticides, solvents, propellants,
combustion products, and fuels.
2
A detailed description of how IOM studies are conducted appears at www.iom.edu/?id=32248.
3
OEF began on October 7, 2001, in Afghanistan.
4
OIF began on March 19, 2003.
1
2 GULF WAR AND HEALTH
Qatar, Bahrain, Jordan, Israel, Lebanon, Syria, Iran, Turkmenistan, Uzbekistan, Tajikistan,
Kyrgyzstan, and Pakistan).
The committee first identified about 100 naturally occurring pathogens that could
potentially have infected US troops during their service in the Gulf War, OEF, or OIF. The
identified pathogens comprise viruses, bacteria, helminths, and protozoa that have been reported
in southwest and south-central Asia, have historically caused outbreaks of illness in military
populations, or have generated particular concern among US veterans of the Persian Gulf War.
As required by PL 105-277 and PL 105-368, the pathogens include Escherichia coli, Shigella
spp., Leishmania spp., and the Phlebovirus pathogens that cause sand fly fever.
• Significant interruption of normal physical and mental function outside the timeframe of acute
infection.
• Persistent organ dysfunction or damage.
• Reproductive effects in military personnel, including birth defects in their offspring.
Many of the diseases have never been reported in US military personnel in close temporal
relationship to deployment to southwest or south-central Asia for the Gulf War, OEF, or OIF.
Even so, the committee could not rule out the possibility that one or more people contracted an
unreported disease during deployment. Consequently, the committee created a tabular summary
of such diseases’ acute and long-term characteristics.
5
In this context, secondary transmission means the spread of a pathogen directly from a primary human host to one
or more other humans.
SUMMARY 3
The committee further defined its infections of focus according to the likelihood that the
primary infection would be subacute or the infected person would be asymptomatic for days to
years, and the adverse health outcome would begin months to years after infection. In such cases,
diagnosis of the long-term adverse health outcome during military service in Asia would be
unlikely, and such infections were candidates for in-depth review and conclusions. In contrast,
military medical personnel would probably diagnose adverse health outcomes that are manifest
during the acute illness or shortly after a person’s deployment.
Finally, the committee examined the likelihood that the candidate infections would have
occurred specifically during military deployment to southwest and south-central Asia during the
three operations in question. The risk of contracting the disease in the theater of operations must
have been equal to or greater than the risk of contracting it in the United States. Moreover, given
the natural history of the disease or infection, it must have been diagnosed in US troops in
appropriate temporal relationship to deployment.
By applying those criteria to the dozens of infectious diseases recognized initially, the
committee identified the group that required in-depth evaluation and conclusions: brucellosis,
Campylobacter infection, leishmaniasis, malaria, Q fever, salmonellosis, and shigellosis. Two
other diseases did not meet all the criteria but still merited in-depth evaluation: tuberculosis and
West Nile virus infection.
Tuberculosis (TB) could cause long-term adverse health outcomes in US troops and
veterans deployed to southwest and south-central Asia, where TB is highly endemic. TB has a
long history of activation and transmission in military settings. Moreover, about 2.5% of military
personnel deployed to OEF and OIF and given predeployment and postdeployment skin tests for
TB converted from negative to positive; that is, these troops acquired new TB infections during
deployment.6 Therefore, although the committee found no published reports of active TB cases
among the troops in question, conclusions about the long-term adverse health outcomes of TB
infection are quite pertinent.
Unlike TB, West Nile virus (WNV) has been reported in troops deployed to southwest
and south-central Asia, where the virus is endemic. The long-term adverse health outcomes
associated with WNV infection are usually manifest during the acute illness—a characteristic
that disqualified other diseases from comprehensive evaluation in this report. Nevertheless,
dramatic changes in the epidemiology of WNV since the mid-1990s led the committee to make
an exception for WNV and to review it in depth.
In addition, a small set of biologic agents, infections, and diseases that failed to meet the
committee’s inclusion criteria nevertheless raised serious questions that merited discussion: Al
Eskan disease, biowarfare agents, idiopathic acute eosinophilic pneumonia, mycoplasmal
infection, and wound infection (including wound infection caused by Acinetobacter baumanii,
the most notable pathogenic colonizer of wounds during OEF and OIF).
Development of Conclusions
6
Kilpatrick ME. 2005. Presentation to IOM Committee on Gulf War and Health: Infectious Diseases. Washington,
DC.
4 GULF WAR AND HEALTH
references. On closer examination, some 1,200 references appeared to provide the requisite types
and quality of scientific evidence for this study.
SUMMARY OF CONCLUSIONS
• Brucellosis and
o Arthritis and spondylitis; arthritis usually is manifest within 12 months of the acute
illness, and spondylitis might be manifest later.
o Hepatic abnormalities, including granulomatous hepatitis.
o Chronic meningitis and meningoencephalitis.
o Uveitis.
o Orchioepididymitis and infections of the genitourinary system.
o Cardiovascular, nervous, and respiratory system infections.
• Campylobacter jejuni infection and Guillain-Barré syndrome (GBS) if GBS is manifest within
2 months of the infection.
• Campylobacter infection and reactive arthritis (ReA) if ReA is manifest within 3 months of
the infection; most cases of ReA are manifest within 1 month of the infection.
• Coxiella burnetii infection (Q fever) and
o Endocarditis years after primary infection.
o Vascular infection years after primary infection.
o Chronic hepatitis years after primary infection.
• Plasmodium malariae infection and manifestation of immune-complex glomerulonephritis
years to decades later.
• Plasmodium falciparum infection and recrudescence weeks to months after the primary
infection, but only in the case of inadequate therapy.
• Nontyphoid Salmonella infection and ReA if ReA is manifest within 3 months of the
infection.
• Shigella infection and
o Hemolytic-uremic syndrome (HUS) if HUS is manifest within 1 month of the
infection; most cases of HUS are manifest within 10 days of the infection.
o ReA if ReA is manifest within 3 months of the infection; most cases of ReA are
manifest within 1 month of the infection.
• Active TB and long-term adverse health outcomes due to irreversible tissue damage from
severe forms of pulmonary and extrapulmonary TB.
• Visceral leishmaniasis (kala-azar) and
o Delayed presentation of the acute clinical syndrome.
o Reactivation of visceral leishmaniasis in the context of future immunosuppression.
o Post-kala-azar dermal leishmaniasis (PKDL) if PKDL occurs generally within 2 years
of the initial infection.
6 GULF WAR AND HEALTH
• West Nile virus infection and variable physical, functional, or cognitive disability, which may
persist for months or years or be permanent.
• Brucellosis and
o Myelitis-radiculoneuritis, demyelinating meningovascular syndromes, deafness,
sensorineural hearing loss, and GBS.
o Papilledema, optic neuritis, episcleritis, nummular keratitis, and multifocal
choroiditis.
o Fatigue, inattention, amnesia, and depression.
• Campylobacter jejuni infection and development of uveitis if uveitis is manifest within 1
month of infection.
• Coxiella burnetii infection and post-Q-fever chronic fatigue syndrome years after the primary
infection.
• Plasmodium falciparum infection and neurologic disease, neuropsychiatric disease, or both
months to years after the acute infection.
• Plasmodium vivax and Plasmodium falciparum infections and demyelinating polyneuropathy
and GBS.
Each branch of the US military has polices regarding tuberculin skin testing and
treatment of latent TB infection (LTBI). The most effective way to mitigate TB transmission and
activation is to identify and treat for LTBI. In addition, the only way to determine whether
military personnel and reservists have become infected with M. tuberculosis during their service
is to test all personnel for TB shortly before and after deployment. Such testing would make it
possible to trace cases of active TB to periods of military service if that is when infection
occurred.
Department of Defense (DOD) policy specifies that predeployment serum specimens for
medical examinations will routinely be collected within 1 year of deployment and that
postdeployment serum specimens for medical examinations will be collected no later than 30
days after arrival at the demobilization site, home station, or in-patient medical treatment facility.
The committee agrees with DOD’s overall policy regarding collection and use of serum
specimens. However, for banked serum specimens to be most useful for determining whether
infectious exposures occurred during deployment, the predeployment specimens need to be
collected before travel. Current policy allows for collection of predeployment serum specimens
up to 1 year after deployment. If the collection of serum is not done until after deployment, it
would be difficult to ascertain whether any signs of infection found in the “predeployment”
specimen are due to exposure during the current deployment or before it.
1
INTRODUCTION
Five days after the Iraqi invasion of Kuwait on August 2, 1990, the United States
deployed troops to Operation Desert Shield (ODSh). The United States attacked Iraqi armed
forces by air on January 16, 1991, and this marked the beginning of Operation Desert Storm
(ODSt). The ground war began on February 24, 1991, and ended 4 days later. The official cease-
fire took effect on April 11, 1991, and the last troops to participate in the ground war arrived
back in the United States on June 13, 1991. In this report, ODSh and ODSt are also referred to
collectively as the Gulf War.
About 697,000 US troops were deployed to the Persian Gulf during ODSh and ODSt.
Figure 1.1 depicts the size of the US military presence in the Persian Gulf from August 1990
through June 1991. The war was considered to be a successful military operation, and there were
few injuries and deaths.
Shortly after returning to the United States, a number of veterans started reporting a
variety of symptoms—fatigue, headache, muscle and joint pain, sleep disturbances, and
cognitive difficulties (Persian Gulf Veterans Coordinating Board 1995). The veterans were
concerned that they might have been exposed to chemical, biologic, or physical agents during
their deployment to the Persian Gulf and that those exposures might be responsible for their
unexplained illnesses.
9
10
500
400
300
200
100
0
Operation Desert Shield (ODSh) Period of Combat
August September October November December January February March April May June July
1990 1991
8/7/90: First US troops arrive in 1/16/91: 4/11/91: 6/13/91: Last US troops
Arabian Peninsula for Operation Desert Operation Desert Official to participate in ground
Shield Storm (ODSt) cease-fire war arrive back in US
begins takes effect
FIGURE 1.1 Operation Desert Shield and Operation Desert Storm: key dates and size of US military presence in theater.
SOURCE: DOD 2006; IOM 2000; PAC 1996.
INTRODUCTION 11
In response to the concerns of the Gulf War veterans about their unexplained illnesses,
the US Department of Veterans Affairs (VA) asked the Institute of Medicine (IOM) to conduct a
study to evaluate the scientific literature on chemical, biologic, and physical agents to which
military personnel in the gulf were potentially exposed and possible long-term adverse health
outcomes. In addition, Congress passed two laws in 1998—the Persian Gulf War Veterans Act
(PL 105-277) and the Veterans Programs Enhancement Act (PL 105-368)—that called for the
review of the scientific literature on specified agents with regard to long-term adverse health
outcomes. That legislation directs IOM to study a number of diverse chemical, biologic, and
physical agents (listed in Box 1.1). IOM divided the task into several reviews. It has completed
four reports: Gulf War and Health, Volume 1: Depleted Uranium, Pyridostigmine Bromide,
Sarin, Vaccines (IOM 2000); Gulf War and Health, Volume 2: Insecticides and Solvents (IOM
2003); Gulf War and Health Volume 3: Fuels, Combustion Products, and Propellants (IOM
2005); and Gulf War and Health, Volume 4: Health Effects of Serving in the Gulf War (IOM
2006). The present report is the fifth volume in the series. An additional, related report has also
been published: Gulf War and Health: Updated Literature Review of Sarin (IOM 2004).
Since VA asked IOM to conduct the above-mentioned study and PL 105-277 and PL
105-368 were enacted, the United States has again entered into military conflicts in southwest
and south-central Asia—Operation Enduring Freedom (OEF) and Operation Iraqi Freedom
(OIF). Therefore, VA has asked IOM to make this report relevant to the military personnel
serving in OEF and OIF in addition to those who served in the 1991 Gulf War.
12 GULF WAR AND HEALTH
In accordance with PL 105-277 and PL 105-368, IOM appointed the Committee on Gulf
War and Health: Infectious Diseases and tasked it to review, evaluate, and summarize the peer-
reviewed scientific and medical literature on long-term adverse health outcomes associated with
selected infectious diseases pertinent to service in the Gulf War. The infectious diseases can
include, but are not limited to, pathogenic Escherichia coli infection, shigellosis, leishmaniasis,
and sand fly fever.
VA is also concerned about potential long-term adverse health outcomes of infectious
diseases in veterans of OEF and OIF. As of October 2005, about 1.2 million US troops have been
deployed to OEF or OIF (see Figure 1.2). VA asked IOM to evaluate infectious diseases
pertinent to service in OEF and OIF.
It should be noted that the charge to IOM was not to determine whether a unique Gulf
War syndrome or Gulf War illness exists or to make judgments about whether individual
veterans were exposed to specific pathogens. Nor was the charge to focus on broader issues, such
as the potential costs of compensation for veterans or policy regarding compensation; such
decisions are the responsibility of the secretary of veterans affairs.
14
450
400
350
300
250
200
150
100
50
September January May Sept January May Sept January May September January May September
2001 2002 2003 2004 2005
10/7/01 3/19/03
Operation Enduring Operation Iraqi
Freedom begins Freedom begins
FIGURE 1.2 Operation Enduring Freedom and Operation Iraqi Freedom: key dates and size of US military presence in theater.
SOURCE: Personal Communication, Michelle Rudolph, Branch Chief, Defense Manpower Data Center, December 15, 2005.
INTRODUCTION 15
A brief overview of how the committee approached its charge is presented here. A more
comprehensive explanation is provided in Chapter 2.
The committee identified numerous infectious diseases to which Gulf War, OIF, and OEF
military personnel might have been exposed during their deployment. Dozens of infectious
diseases are endemic to southwest and south-central Asia, which includes Iraq, Kuwait, and
Afghanistan. The committee then determined which of the endemic infectious diseases are
known to have long-term adverse health outcomes. To determine which infectious diseases to
review in depth, the committee took several factors into account, including which ones were
diagnosed in military personnel who served in the Gulf War, OEF, or OIF and in veterans after
they returned home, as well as the prevalence of the infectious diseases in southwest and south-
central Asia compared with their prevalence in the United States.
Overall, the incidence of infectious diseases among Gulf War military personnel was low
(Hyams et al. 1995). Acute diarrheal and acute respiratory diseases were the major causes of
morbidity from infectious diseases (Hyams et al. 1995; Hyams et al. 2001). The outbreaks of
diarrhea were due primarily to enterotoxigenic Escherichia coli and Shigella sonnei. Some 12
cases of viscerotropic leishmaniasis and 20 cases of cutaneous leishmaniasis were diagnosed in
Gulf War military personnel (Hyams et al. 1995; Hyams et al. 2001). Other reported infectious
diseases included Q fever (three cases), West Nile fever (one case), and malaria (seven cases)
(Hyams et al. 1995; Hyams et al. 2001).
Infectious diseases reported in troops who served in OEF and OIF as of December 2005
are visceral and cutaneous leishmaniasis, malaria, diarrheal disease, respiratory disease,
tuberculosis infection (but not active tuberculosis), Q fever, brucellosis, and Acinetobacter
baumannii infection (Kilpatrick 2005). Chapter 4 reviews the literature on infectious diseases
that have been diagnosed in military personnel during or shortly after returning from the Gulf
War, OIF, or OEF.
The committee identified for comprehensive evaluation nine infectious diseases known to
have long-term adverse health outcomes that were diagnosed in military personnel who served in
the Gulf War, OEF, or OIF. Some information is presented on a number of other infectious
diseases as well because they are endemic to southwest and south-central Asia, although there
have been no reported cases in military personnel through December 2005. It is possible that
military personnel have become infected but that no diagnosis was made either because no acute
symptoms were present or because the symptoms were mild and the soldier who had them did
not seek medical care. We also present information on diseases and agents of special concern to
veterans of the Gulf War, OEF, and OIF (Al Eskan disease, acute eosinophilic pneumonia,
Acinetobacter baumannii infection, mycoplasmas, and biological warfare agents).
After determining which infectious diseases it would evaluate, the committee had to
identify the relevant literature for review. The committee relied primarily on peer-reviewed
published literature in developing its conclusions. It also consulted other material, such as
surveillance reports, technical reports, and textbooks, and it obtained additional information from
experts in infectious diseases of southwest and south-central Asia, from Deployment Health
Support at the Department of Defense (DOD), from Walter Reed Army Institute of Research,
from the VA Occupational and Environmental Health Strategic Healthcare Group, and from
veteran service organizations and Gulf War veterans. The committee focused on medical and
16 GULF WAR AND HEALTH
scientific data on long-term adverse health outcomes related to the infectious diseases it selected
for study.
The final step in the committee’s evaluation process was to weigh the evidence on the
infectious diseases and their long-term adverse health outcomes and to develop conclusions
about the strength of the evidence. The conclusions are assigned to categories of association,
which range from sufficient evidence of a causal relationship to insufficient or inadequate
evidence of an association.
This report includes discussion of acute diseases with potential long-term adverse health
outcomes caused by known pathogens. The committee acknowledges that there might be
clinically important pathogens that cannot be detected with available cultivation techniques
(Relman 2002). Because the extent to which such pathogens might contribute to acute illnesses
in military personnel is unknown, it is not possible to define a relationship between them and an
acute illness or long-term adverse health outcome.
Chapter 2 lays out the committee’s process for selecting the infectious diseases to study
and reviewing and evaluating the evidence on them. Chapter 3 presents, in tabular format, the
endemic infectious diseases of southwest and south-central Asia that are known to have long-
term adverse health outcomes. Chapter 4 summarizes the body of literature on infectious diseases
that have been diagnosed in military personnel serving in the Gulf War, OIF, and OEF. The
committee’s comprehensive evaluations of selected infectious diseases are presented in Chapter
5, which also contains the committee’s conclusions. The final chapter, Chapter 6, presents
information about diseases and agents of special concern to veterans of the Gulf War, OIF, and
OEF that have an infectious component or have been implicated as a cause of “Gulf War
illness”.
REFERENCES
IOM. 2005. Gulf War and Health, Volume 3: Fuels, Combustion Products, and Propellants.
Washington, DC: The National Academies Press.
IOM. 2006. Gulf War and Health, Volume 4: Health Effects of Serving in the Gulf War.
Washington, DC: The National Academies Press.
Kilpatrick ME. 2005. Presentation to IOM Committee on Gulf War and Health: Infectious
Diseases. Washington, DC.
PAC (Presidential Advisory Committee). 1996. Presidential Advisory Committee on Gulf War
Veterans’ Illnesses: Final Report. Washington, DC: US Government Printing Office.
Persian Gulf Veterans Coordinating Board. 1995. Unexplained illnesses among Desert Storm
veterans. A search for causes, treatment, and cooperation. Persian Gulf Veterans
Coordinating Board. Archives of Internal Medicine 155(3):262-268.
Relman DA. 2002. New technologies, human-microbe interactions, and the search for previously
unrecognized pathogens. Journal of Infectious Diseases 186(2 Suppl):S254-S258.
2
METHODOLOGY
This chapter articulates the committee’s approach to its task. Of the dozens of pathogens
known to exist in southwest and south-central Asia, the committee identified the ones that are
known to cause long-term adverse health outcomes and infected at least one US veteran who
served in southwest or south-central Asia in the period 1991-December 2005. The committee
then oversaw a formal, comprehensive literature review that identified about 1,200 peer-
reviewed studies about the late complications and latent and chronic infections that might be
associated with primary infection by each of the pathogens. Those studies constituted the
evidence from which the committee drew conclusions about the relationship between each
primary infection and specific long-term adverse health outcomes in humans. Finally, the
committee ranked the strength of the relationships through the five-category system presented at
the end of this chapter.
Geographic Boundaries
As required by law, the committee considered infectious diseases that might have
afflicted US troops who served in the 1991 Gulf War (PL 105-277 and PL 105-368).
Additionally, in response to a request by the Department of Veterans’ Affairs, the committee
considered infectious diseases that might have afflicted US troops during Operation Enduring
Freedom (OEF) or Operation Iraqi Freedom (OIF). Thus, the committee’s preliminary
deliberations covered infectious diseases known to occur specifically in Iraq, Kuwait, and
Afghanistan and in the geographic region that includes the Arabian Peninsula, Syria, Lebanon,
Israel, Iran, Qatar, Pakistan, Tajikistan, Kyrgyzstan, Uzbekistan, and Turkmenistan (Figure 2.1).
The term southwest and south-central Asia refers to that region throughout this report.
19
20 GULF WAR AND HEALTH
Uzbekistan
Kyrgyzstan
Turkmenistan
Tajikistan
Lebanon Syria
Iraq Afghanistan
Israel Iran
Jordan
Kuwait Pakistan
Qatar
Bahrain Qatar
Saudi United
Arabia Arab
Oman Emirates
Yemen
FIGURE 2.1 Southwest and South-Central Asia. The committee’s preliminary deliberations covered infectious
diseases known to occur specifically in Iraq, Kuwait, and Afghanistan and in the geographic region that includes the
Arabian Peninsula, Syria, Iran, Qatar, Pakistan, Tajikistan, Kyrgyzstan, Uzbekistan, and Turkmenistan.
SOURCE: The National Academies Press.
Infectious Diseases Endemic to Southwest and South-Central Asia That Have Long-Term
Adverse Health Outcomes
The committee approached its task by first identifying infectious diseases that could have
affected US troops deployed to southwest and south-central Asia. The committee members drew
upon their collective knowledge of infectious diseases, which stems from both professional
experience (Appendix A) and information gathered specifically for this study. The committee
acquired information from numerous sources about illnesses diagnosed in troops deployed to
southwest and south-central Asia, infectious diseases known to occur in that region, and
conditions of special interest to veterans. The information came from peer-reviewed journal
articles, surveillance and technical reports, presentations by physicians and scientists, and
veterans and representatives of veterans’ groups.
METHODOLOGY 21
TABLE 2.1 Diseases and Etiologic Agents Considered by the Committee for Evaluation
Disease Etiologic Agent
Bacterial diseases
Acinetobacter infection Acinetobacter baumanii and other Acinetobacter species
Actinomycosis Actinomyces spp.
Anthrax Bacillus anthracis
Bartonellosis Bartonella spp.
Cat-scratch disease B. henselae
Trench fever B. quintana
Botulism Clostridium botulinum
Brucellosis Brucella spp.
Campylobacteriosis Campylobacter spp.
Capnocytophaga infection Capnocytophaga spp.
Chlamydia
Genital infections Chlamydia trachomatis
Pneumonia Chlamydia pneumoniae
Cholera (including vibrio infections) Vibrio spp.
Diphtheria Corynebacterium diphtheriae
E. coli gastroenteritis Escherichia coli
Enterotoxigenic E. coli
Shiga toxin-producing E. coli
Enteroaggregative E. coli
Enteroinvasive E. coli
Enterohemorrhagic E. coli
Enteropathogenic E. coli
Ehrlichioses Ehrlichia spp.
Enteric fever
Paratyphoid fever Salmonella enterica serovar Paratyphi A,B,C
Typhoid fever Salmonella enterica serovar Typhi
Enterococcal infection (vancomycin-resistant) Enterococcus spp.
Gas gangrene Clostridium perfringens
Hemophilus meningitis Haemophilus influenzae
Helicobacter infection Helicobacter pylori
Klebsiella infection Klebsiella spp.
Legionnaire’s disease Legionella spp.
Leptospirosis Leptospira spp.
Listeriosis Listeria monocytogenes
Lyme disease Borrelia burgdorferi
Melioidosis Burkholderia pseudomallei
Meningococcal infection Neisseria meningitidis
Moraxella infection Moraxella catarrhalis
22 GULF WAR AND HEALTH
Leishmaniasis
Sand fly fever
Pathogenic Escherichia coli infection
Shigellosis
• Substantial interruption of normal physical and mental functioning occurring outside the
timeframe of acute infection.
• Organ dysfunction or damage with a persistent effect.
• Reproductive effects in military personnel, including birth defects in offspring of military
personnel.
A long-term adverse health outcome may be reversible. The committee also considered the
potential for secondary transmission of the pathogen.
The application of these criteria to the infectious diseases listed in Table 2.1 generated
the infectious diseases contained in Box 2.2: infectious diseases that are endemic to southwest
and south-central Asia and have long-term adverse health outcomes.
The committee examined the likelihood that the candidate infections would have
occurred specifically during military deployment to southwest and south-central Asia during the
METHODOLOGY 25
three operations in question. The risk of contracting a disease in the theater of operations must
have been equal to or greater than the risk of contracting it in the United States. Moreover, given
the natural history of the disease or infection, it must have been diagnosed in US troops in
appropriate temporal relationship to deployment.
Chapter 4 comprises a review of infectious diseases that have been reported in US troops
in close temporal relationship to the operations under study. On the basis of that review, the
committee determined that many of the diseases in Box 2.2 have never been reported in US
military personnel in close temporal relationship to deployment to southwest or south-central
Asia during the Gulf War, OEF, or OIF. Nevertheless, it is impossible to prove that US troops
did not contract any of the unreported diseases during deployment. Thus, the committee
summarizes the acute and long-term characteristics of these unreported diseases in tabular form
in Chapter 3 and excludes them from further analysis.
BOX 2.2 Infectious Diseases That Are Endemic in Southwest and South-Central Asia and Have Long-Term
Adverse Health Outcomes
Type of Etiologic Agent
Bacterium Virus Protozoan Helminth
More prevalent in southwest or More prevalent in More prevalent in More prevalent in
south-central Asia than in the southwest or south- southwest or south- southwest or south-
United States central Asia than in the central Asia than in central Asia than in
Anaplasmosis United States the United States the United States
Anthrax Crimean-Congo Amebiasis Ascariasis
Boutonneuse fever hemorrhagic fever Cryptosporidiosis Cysticercosis
Brucellosis Dengue fever Cyclosporiasis Echinococcosis
Campylobacter infection Dengue hemorrhagic fever Giardiasis Enterobiasis
Chancroid Dengue shock syndrome Isosporiasis Filariasis
Cholera Hepatitis A Leishmaniasis Hookworm disease
E. coli gastroenteritis Hepatitis B Malaria Onchocerciasis
Ehrlichiosis Hepatitis C Microsporidiosis Schistosomiasis
Enteric fever Rift Valley fever Toxoplasmosis Strongyloidiasis
Helicobacter infection Sand fly fever
Leptospirosis Sindbis
Lymphogranuloma venereum
Melioidosis Potentially more
Plague prevalent among troops
Q fever in war theater than
Rat bite fever among US adult
Relapsing fever population
Salmonellosis (nontyphoid) Adenovirus infection
Shigellosis Avian influenza
Syphilis Hantaviral hemorrhagic
Tuberculosis fever with renal
Typhus group (louse-borne and syndrome
murine) Hantavirus pulmonary
Yaws syndrome
Yersinia enterocolitica infection Influenza
Viral enteritis
Potentially more prevalent among West Nile fever
troops in war theater than among
US adult population
Gonorrhea
Trichomoniasis
26 GULF WAR AND HEALTH
Antibiotic-resistant or common
nosocomial infections
Infections caused by
Acinetobacter (Multiple drug-
resistant)
Enterococcus (vancomycin-resistant)
Klebsiella (multiple drug-resistant)
Pseudomonas aeruginosa
Staphylococcus aureus (methicillin-
resistant)
Stenotrophomonas maltophilia
Next, the committee determined the likelihood that a disease’s long-term adverse health
outcomes would have been manifest and diagnosed during a person’s term of military service.
If the onset of adverse health outcomes typically occurs during the acute illness, the
committee reasoned, the long-term effects would probably be detected, diagnosed, and reported
during the patient’s term of military service. Likewise, diseases that have an acute phase—
meaning that signs and symptoms become evident suddenly within hours or days of infection—
are readily diagnosed during military service if the individual seeks medical care; in such cases,
the physician would probably be cognizant of possible long-term adverse health outcomes.
Finally, pre-existing conditions that were mild or latent before deployment but became
reactivated or exacerbated during deployment also would probably be diagnosed during the
patient’s military service. Therefore, infectious diseases with one or both of the following
characteristics were not comprehensively evaluated in this study; instead, their acute and long-
term health outcomes are summarized in tabular form in Chapter 3:
• Onset of long-term adverse health outcomes typically occurs during the acute illness.
• The disease is a preexisting infection that becomes reactivated or exacerbated during
deployment.
In contrast, the committee determined, there are other infectious diseases whose long-
term adverse health outcomes were unlikely to be diagnosed during military service in southwest
and south-central Asia. Such diseases have the following characteristics:
• The primary infection is subacute or the infected person is asymptomatic for days to years.
• Long-term adverse health outcomes begin months to years after infection.
Because a subacute infection may go unnoticed and undiagnosed, the committee reasoned, the
primary disease might not be reported. Furthermore, if long-term adverse health outcomes begin
months or even years after infection, the condition would be more likely to be diagnosed after
the person completes military service, and the diagnosing physician may not attribute the
patient’s signs and symptoms to an infection acquired during deployment, particularly if the
disease is uncommon in the United States, and thus more likely to be misdiagnosed. Infectious
diseases that fit those criteria qualified for in-depth study.
The Infectious Diseases to Be Studied for Strength of Association with Long-Term Adverse
Health Outcomes
The committee identified nine infectious diseases (Box 2.3) known to have long-term
adverse health outcomes and to be potentially acquired by infected veterans during their military
deployment to southwest and south-central Asia from 1991 to 2005. The committee conducted
comprehensive reviews of the literature on the potential long-term adverse health outcomes of
these diseases to determine the strength of association between the primary infection and the
health outcome in humans.
28 GULF WAR AND HEALTH
Brucellosis
Campylobacteriosis
Leishmaniasis
Malaria
Q fever
Salmonellosis
Shigellosis
Tuberculosis
West Nile fever
Reasons for Excluding E. coli and Sand Fly Fever from In-Depth Study
Two of the infectious diseases named in PL 105-277 and PL 105-368—E. coli and sand
fly fever—do not fulfill the above criteria for in-depth evaluation.
E. coli
Diarrheal infections were among of the most common ailments diagnosed in military
personnel in regional theaters, and pathogenic E. coli is a well-recognized cause of diarrheal
syndromes. The committee considered various infections related to pathogenic E. coli, focusing
its attention on the role of pathogenic E. coli in diarrheal diseases. The unifying clinical
syndrome associated with the various E. coli infections is a diarrheal illness that in healthy adults
is usually transient without long-term adverse health outcomes. Therefore, the committee
summarizes the health outcomes of E. coli infections in Chapter 3.
Sand Fly Fever
There are no published reports of sand fly fever in military personnel who served in the
Gulf War; however, results from a search, requested by the Institute of Medicine (IOM), of a
Department of Defense Gulf War hospitalization database identified five cases of this disease
(the database and the search results are described in Chapter 4). As of December 2005, sand fly
fever has not been found in military personnel serving in OIF and OEF. Sand fly fever is
associated with a long-term adverse health outcome; however, the onset of the health outcome
typically occurs during the acute illness. Therefore, the committee summarizes the health
outcomes of sand fly fever in Chapter 3.
Comments on Diseases and Agents of Special Interest to Gulf War, OEF, and OIF Veterans
Several diseases and agents are of special interest to veterans of the Gulf War, OEF, and
OIF. There is concern among Gulf War veterans that their symptoms might be connected to
infection with Mycoplasma fermentans from contaminated vaccines (Nicolson et al. 2003) or
exposure to biologic-warfare agents. In addition, during the Gulf War, troops stationed at Al
Eskan Village, Saudi Arabia, developed respiratory illnesses at a high rate (Korenyi-Both et al.
1997; Korenyi-Both et al. 1992). The disease was termed Al Eskan disease and it has been
hypothesized that a pathogen might be the cause. More recently, idiopathic acute eosinophilic
pneumonia (IAEP) has been diagnosed in 18 military personnel serving in OIF or OEF (Shorr et
al. 2004). IAEP is a syndrome characterized by febrile illness, diffuse pulmonary infiltrates, and
pulmonary eosinophila (Allen et al. 1989; Badesch et al. 1989; Philit et al. 2002). There is also a
METHODOLOGY 29
The committee oversaw a multistep process for amassing a robust collection of scientific
literature about the long-term adverse health outcomes of the diseases listed in Box 2.3. The
process began with a search of PubMed, a database created and managed by the National Library
of Medicine that includes more than 15 million citations of biomedical publications from the
1950s to the present. The PubMed search focused on journal articles published through
December 2005 that contain information about late complications, long-term sequelae, and latent
infections related to the relevant infectious diseases and etiologic agents identified by the
committee. Additional studies were identified from the reference lists of topical technical reports,
textbooks, and other documents. Further PubMed searches identified pertinent articles on Al
Eskan disease, IAEP, wound-associated infections, mycoplasmas, and biologic-warfare agents.
Those initial searches generated about 20,000 articles.
On closer examination of that large body of literature, a subset of about 1,200 articles
appeared to provide the types and quality of scientific evidence that the committee needed to
accomplish its task. After securing the full text of those articles, the committee reviewed and
assessed them for evidence of associations between primary infections by the etiologic agents of
interest and specific long-term adverse health outcomes in humans.
The committee included several types of studies, including epidemiologic studies, case
reports, and case series. Ideally, epidemiologic studies should have methodologic details, a
control or reference group, reasonable adjustment for confounders, and statistical power to detect
effects. Review articles, technical reports, and textbooks were used for background information.
The committee relied heavily on studies that focused on human adult populations.
Because the IOM task concerns adults who may have become infected during military service,
studies of children were generally excluded unless the studies dealt with reproductive outcomes.
One exception is that studies of children were included if they provided information about adult
30 GULF WAR AND HEALTH
diseases; for example, a study on cerebral malaria in children might be reviewed if it provided
information about the disease in adults.
The committee’s goal was to use the evidence in the medical and scientific literature to
determine the relationships between the infectious diseases of interest and specific adverse health
outcomes that might appear months to years after primary infections. Those relationships,
presented in Chapter 5, are conceived in terms of the “strength of association” between a primary
infection and a specific long-term adverse health outcome. The committee ranks strength of
association qualitatively using a five-tier system, presented below in full.
Evidence from available studies is sufficient to conclude that there is a causal relationship
between exposure to a specific agent and a specific health outcome in humans. The evidence
includes supporting experimental data and fulfills the guidelines for sufficient evidence of an
association (see next category). The association is biologically plausible, and the evidence
satisfies several of the guidelines used to assess causality, such as strength of association, dose-
response relationship, consistency of association, and a temporal relationship.
METHODOLOGY 31
REFERENCES
Allen JN, Pacht ER, Gadek JE, Davis WB. 1989. Acute eosinophilic pneumonia as a reversible
cause of noninfectious respiratory failure. New England Journal of Medicine 321(9):569-574.
Badesch DB, King TE Jr., Schwarz MI. 1989. Acute eosinophilic pneumonia: A hypersensitivity
phenomenon? American Review of Respiratory Disease 139(1):249-252.
CDC (Centers for Disease Control and Prevention). 2005. Health Information for International
Travel 2005-2006. Centers for Disease Control and Prevention. Atlanta, GA: US Department
of Health and Human Services, Public Health Service.
Davis KA, Moran KA, McAllister CK, Gray PJ. 2005. Multidrug-resistant Acinetobacter
extremity infections in soldiers. Emerging Infectious Diseases 11(8):1218-1224.
Heymann DL. 2004. Control of Communicable Diseases Manual. Washington, DC: American
Public Health Association.
32 GULF WAR AND HEALTH
IARC (International Agency for Research on Cancer). 1998. Preamble to the IARC Monographs.
[Online]. Available: http://www-cie.iarc.fr/monoeval/background.html [accessed July 19,
2005].
IARC. 1999a. Evaluation. Preamble to the IARC Monographs. [Online]. Available: http://www-
cie.iarc.fr/monoeval/eval.html [accessed August 3, 2005].
IARC. 1999b. Objective and Scope. Preamble to the IARC Monographs. [Online]. Available:
http://www-cie.iarc.fr/monoeval/objectives.html [accessed August 3, 2005].
IARC. 2005. Monographs on the Evaluation of Carcinogenic Risks to Humans. [Online].
Available: http://www-cie.iarc.fr/ [accessed August 3, 2005].
IOM (Institute of Medicine). 1991. Adverse Effects of Pertussis and Rubella Vaccines.
Washington, DC: National Academy Press.
IOM. 1994a. Adverse Events Associated With Childhood Vaccines: Evidence Bearing on
Causality. Washington, DC: National Academy Press.
IOM. 1994b. Veterans and Agent Orange: Health Effects of Herbicides Used in Vietnam.
Washington, DC: National Academy Press.
IOM. 1996. Veterans and Agent Orange: Update 1996. Washington, DC: National Academy
Press.
IOM. 1999. Veterans and Agent Orange: Update 1998. Washington, DC: National Academy
Press.
IOM. 2000a. Clearing the Air: Asthma and Indoor Air Exposures. Washington, DC: National
Academy Press.
IOM. 2000b. Gulf War and Health, Volume 1: Depleted Uranium, Sarin, Pyridostigmine
Bromide, Vaccines. Washington, DC: National Academy Press.
IOM. 2001. Veterans and Agent Orange: Update 2000. Washington, DC: National Academy
Press.
IOM. 2003a. Gulf War and Health, Volume 2: Insecticides and Solvents. Washington, DC: The
National Academies Press.
IOM. 2003b. Veterans and Agent Orange: Update 2002. Washington, DC: The National
Academies Press.
IOM. 2004. Gulf War and Health: Updated Literature Review of Sarin. Washington, DC: The
National Academies Press.
IOM. 2005. Gulf War and Health, Volume 3: Fuels, Combustion Products, and Propellants.
Washington, DC: The National Academies Press.
Korenyi-Both AL, Korenyi-Both AL, Molnar AC, Fidelus-Gort R. 1992. Al Eskan disease:
Desert Storm pneumonitis. Military Medicine 157(9):452-462.
Korenyi-Both AL, Korenyi-Both AL, Juncer DJ. 1997. Al Eskan disease: Persian Gulf
syndrome. Military Medicine 162(1):1-13.
Mandell GL, Bennett JE, Dolin R. 2005. Principles and Practice of Infectious Diseases. 6th ed.
Philadelphia, PA: Elsevier Churchill Livingstone.
Nicolson GL, Nasralla MY, Nicolson NL, Haier J. 2003. High prevalence of mycoplasma
infections in symptomatic (Chronic Fatigue Syndrome) family members of mycoplasma-
positive Gulf War illness patients. Journal of the Chronic Fatigue Syndrome 11(2):21-36.
METHODOLOGY 33
In Chapter 2, the committee developed an extensive list of infectious diseases that are
endemic to southwest and south-central Asia (Table 2.1) and then narrowed the list to diseases or
syndromes with known long-term adverse health outcomes (Box 2.2). Although most diseases in
that subset have not been reported in military personnel deployed to southwest and south-central
Asia, they have historically been diagnosed in local populations and thus pose a theoretical risk
to US troops deployed to the region. Also, given the nature and duration of Operation Iraqi
Freedom and Operation Enduring Freedom, some of the diseases in Box 2.2 could be diagnosed
after a person’s deployment or period of military service.
The committee decided that the most effective way to give additional information on the
diseases listed in Box 2.2 would be to present them in tables containing
Tables 3.1-3.4 categorize the infections of interest by type of pathogen (viral, bacterial,
helminthic, or protozoan), and Table 3.5 describes sexually transmitted diseases. The infectious
diseases with long-term adverse health outcomes that have been diagnosed in military personnel
and that the committee reviewed in depth (see Chapter 5) are also included here.
35
Exploring the Variety of Random
Documents with Different Content
The Project Gutenberg eBook of Work of the
Colored Law and Order League, Baltimore, Md.
This ebook is for the use of anyone anywhere in the United
States and most other parts of the world at no cost and with
almost no restrictions whatsoever. You may copy it, give it away
or re-use it under the terms of the Project Gutenberg License
included with this ebook or online at www.gutenberg.org. If you
are not located in the United States, you will have to check the
laws of the country where you are located before using this
eBook.
Language: English
Executive Committee
Rev. John A. Holmes
Harry T. Pratt
Dr. Whitfield Winsey
Heber E. Wharton
Josiah A. Diggs
Mason A. Hawkins
Rev. John T. Jenifer
W. C. McCard
W. Ashbie Hawkins
Dr. J. H. N. Waring
PRESS OF
E. A. Wright Bank Note Co.
PHILADELPHIA, PA.
Work of the Colored Law and
Order League :: Baltimore, Md.
by James H. N. Waring
Committee of Twelve
FOR THE ADVANCEMENT OF THE INTERESTS OF THE NEGRO RACE
Cheyney, Pa.
MAP
SHOWING
LOCATION OF SALOONS
A map of the lower Druid Hill Avenue District. In this district there were forty-two
saloons, fifteen churches, twelve schools, one home for old people, one home for
friendless children, the colored Y. M. C. A. and the colored Y. W. C. A.
Work of the Colored Law and Order League of Baltimore
This district is infested with dives and disorderly houses. The small dots indicate
the disorderly houses; the large dots liquor saloons; the crosses around them are
liquor saloons which have disorderly houses connected with them; the small
triangles are houses that are suspected.
In this district some of the women who keep these houses have their names
printed over the doors.
Deaths due to tuberculosis in ten years, 1891–1900, inclusive, in all 11,542. The
tuberculosis map of Baltimore City. The lower Druid Hill Avenue district is
outlined on the map. This is the tuberculosis center of Maryland and the City of
Baltimore.
The Druid Hill Avenue district is the largest and most populous
colored neighborhood in Baltimore, if not in the world. It probably
contains more homes owned and occupied by colored people than
any similar residential neighborhood anywhere. It extends from
Eutaw Street to North Avenue, and with the adjacent streets covers
an area a mile and a half long by from one-sixteenth to one-half a
mile wide. The upper part of this district is as fine a colored
neighborhood as one would wish to see, and is comparatively free
from nuisances of any kind.
In the lower Druid Hill Avenue district, which was the largest
district studied, it was found that in a section seven blocks long and
two blocks wide there were located forty-two saloons, fifteen
churches, twelve schools, one home for old people, one home for
friendless children, the Colored Young Men’s Christian Association
and the Colored Young Women’s Christian Association. This section
was honeycombed with gambling dens, known not only to the
initiated, but carrying on unblushingly a business which was known
to the citizens if not to the police. There were numerous dance
houses, clubs and billiard halls which were in actual practice only
assignation places for girls and young women, and to which many of
them owed their downfall.
The Health Office furnished a map which showed that the lower
Druid Hill Avenue district was the “tuberculosis centre” for the city of
Baltimore and the State of Maryland. From “A Study on Housing
Conditions in Baltimore,” an investigation prepared under the
direction of the Association for the Improvement of the Condition of
the Poor and the Charity Organization Society, the following is
quoted, showing the bad conditions of health, sanitation and morals
with reference to one alley in this district:
“The Biddle Alley district, of all sections of the city, holds the record for
the tuberculosis death rate. In the year 1906 eight deaths from
tuberculosis occurred in families known to the agent of the Federated
Charities, and according to the statement made a short time ago by a
Health Department official, there is not a house on Biddle Alley in which
there has not been at least one case of tuberculosis.”
“From morning until midnight the beer can circulates with a regularity
that is almost monotonous.”
“Another striking characteristic of the occupants of this district is what
appears to be in many cases an entirely undeveloped moral sense.”
“Gambling is also prevalent and there is reason to believe that the
cocaine habit hastens the decay of many of these degenerates.”
A common belief is that colored men will not work. The United States census
shows more colored men at work in Maryland than whites.
For instance, there was a query as to why the colored man will not
work. They intimated that in some cases the conditions of vice and
immorality grew out of the laziness and idleness of the men of this
neighborhood as well as out of the environments of the saloons and
dives. A study of the statistics prepared by the United States Census
Bureau, however, shows that a larger percentage of the colored men
of Maryland are at work than of the whites.
The committee was also asked why there is so little home life
among the colored people. It is true that the home life is not as
desirable among colored people as it ought to be and as most of us
would have it; but the influx of the colored population from the
alleys and small streets of south and east Baltimore into the more
desirable neighborhoods of northwest Baltimore, particularly upper
Druid Hill Avenue and the adjacent streets, shows an upward
movement along this line, and the fact that there is a most healthy
and promising growth of the home spirit. Not only this, but statistics
from the United States Census Bureau show that out in the country
districts of Maryland the colored people are procuring homes for
themselves. While it is true that there is a scarcity of labor, it is also
true that there has been a phenomenal increase in the number of
farm homes in the State of Maryland. At the present time the
colored farmers of the State own fifty-seven per cent. of the farm
lands they are tilling.
The committee was also asked why there was so much immorality
among colored women and girls. The exhibition of the charts
showing the conditions surrounding the colored public schools,
particularly the Caroline and Bank Streets neighborhood and the
Rogers Avenue neighborhood, are complete answers to this
question. It was not difficult to see that girls who attended school
among such surroundings as these could not in the very nature of
the case have high ideas of virtue and morality. It was found that at
least five of the colored city schools are surrounded by such
conditions. Little girls and boys receive daily object lessons in
prostitution, gambling, drunkenness, profanity and thieving.
Another distressing question which the committee was constantly
called upon to meet was—Why is the colored jail population so
large? The statistics show that about three-fourths of the population
in the Baltimore jail and the Maryland Penitentiary are colored men
and women—a most disgraceful showing on the part of the colored
people. The committee could only admit that the undue proportion
of colored criminals in the jail and the penitentiary is a reflection
upon the citizenship of the colored people.
ISAAC WINDER
Educating a Negro is cheaper than hanging him.
The committee made the general plea, though, to the white men
upon whom they called, that the colored children should have the
opportunity as a result of their environments and the general
advantages offered them, to grow up into decent citizenship. These
gentlemen were shown the conditions which surrounded our
schoolhouses, and readily admitted the handicap which such
surroundings imposed upon little children. We were able to show
them that the Colored High School, which the city has maintained for
about twenty-five years, has in all of its history furnished but one
inmate for the penitentiary or the jail. Those who are graduated
from this school not only do not join this jail population, but they are
engaged in such occupations in this community as prove their
usefulness to the people with whom they are associated and of
whom they are a part, and at the same time the wisdom of a liberal
policy of education.
The committee was able to show another striking illustration of
the value of education in presenting the history of the notorious Ike
Winder, who murdered a tollgate keeper in Baltimore county. To
arrest, try, imprison, recapture and execute Ike Winder cost the
State two thousand dollars more than it cost to educate one of the
graduates of the Colored High School. The State not only lost in this
expenditure the money involved in the expense connected with the
case, but lost the economic value of an educated citizen. The
educated, trained graduates of the high school exert a most helpful
influence in the community. Assuming that Winder, if he had
graduated from the High School, would have been like the other
graduates, the State lost also the moral influence of this kind of
citizen.
The educated man is a more valuable citizen than the ignorant one.
The facts presented to these men as they were visited formed the
basis of a plea for co-operation between the best whites and blacks
of the city, and the formulation of a plan of action to be mutually
worked out by them. Dr. Gilman, who had taken such an enthusiastic
interest in the matter, offered the use of his home and invited a
conference of gentlemen, which marked an epoch in the approach to
the ideal working relation between the best people of both races.
There were present at this meeting: Postmaster W. Hall Harris; Dr. J.
H. Hollander, a Johns Hopkins professor and one of the noted
sociologists of the age; Dr. Bernard C. Steiner, librarian of the Pratt
Library; Professor Charles W. Hodell, of the Woman’s College;
Lawyers A. M. Tyson and P. C. Hennighausen, R. H. Smith, John C.
Rose, Joseph Packard, Mr. Douglas M. Wylie, Professor James H. Van
Sickle, the Superintendent of Public Instruction; Bishop Paret, Judge
Heuisler, of the Supreme Court; Mr. John M. Glenn, Mr. Eugene
Levering, Dr. Ira Remsen, President of Johns Hopkins University;
Dean Griffin, of Johns Hopkins University, and Dr. Gilman. Many of
these men had been visited by the sub-committee and had had the
matter partially explained to them, but at this gathering in Dr.
Gilman’s house the committee was able to present in detail the
charts which had been prepared, many pictures which had been